Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9267117 Mapping cytosine modifications

Patent 9267117 was granted and assigned to NEW ENGLAND BIOLABS, INC. on February, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

92671170

Patent Inventor Names

Zhenyu Zhu0

Aine Quimby0

Ivan R. Correa, Jr.0

Janine Borgaro0

Nan Dai0

Shengxi Guan0

Date of Patent

February 23, 2016

Patent Application Number

138263950

Date Filed

March 14, 2013

Patent Citations Received

‌

US Patent 12024750 Methylation markers and targeted methylation probe panel

‌

US Patent 11685958 Methylation markers and targeted methylation probe panel

‌

US Patent 12018320 Selective oxidation of 5-methylcytosine by TET-family proteins

Patent Primary Examiner

‌

Nashaat Nashed

Patent abstract

Methods, compositions and kits for selectively altering and detecting modified cytosine residues are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9267117 Mapping cytosine modifications

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API